{"q": "Using the modified Pedersen hypothesis, explain how maternal hyperglycemia leads to fetal macrosomia.", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.25}
{"q": "Explain how normal pregnancy physiology progresses to GDM when beta-cell compensation fails.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.17647058823529413}
{"q": "How does failure to address postpartum follow-up represent a systemic gap in GDM care rather than individual noncompliance?", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.25925925925925924}
{"q": "Compare guideline approaches to screening and diagnostic criteria for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "How do monitoring targets and interventions reduce GDM-related complications?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain how maternal glucose exposure reaches the fetus via placental transfer.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "In mechanistic steps, why does maternal hyperglycemia lead to fetal hyperglycemia (placental glucose transfer)?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "Describe the maternal-to-fetal glucose transfer step in the modified Pedersen hypothesis. Include key intermediates and directionality.", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.25}
{"q": "Explain how maternal glucose exposure reaches the fetus via placental transfer. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Why does maternal hyperglycemia lead to fetal hyperglycemia (placental glucose transfer)?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Describe the maternal-to-fetal glucose transfer step in the modified Pedersen hypothesis.", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.2608695652173913}
{"q": "In mechanistic steps, explain how maternal glucose exposure reaches the fetus via placental transfer.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Why does maternal hyperglycemia lead to fetal hyperglycemia (placental glucose transfer)? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.48148148148148145}
{"q": "Describe the maternal-to-fetal glucose transfer step in the modified Pedersen hypothesis. Use a concise 4\u20136 step causal chain.", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.2727272727272727}
{"q": "In mechanistic steps, describe the maternal-to-fetal glucose transfer step in the modified Pedersen hypothesis.", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.30434782608695654}
{"q": "Explain how maternal glucose exposure reaches the fetus via placental transfer. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4074074074074074}
{"q": "Why does maternal hyperglycemia lead to fetal hyperglycemia (placental glucose transfer)? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Why does fetal hyperglycemia trigger fetal hyperinsulinemia?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.5185185185185185}
{"q": "In mechanistic steps, explain the fetal pancreatic insulin response to increased glucose exposure.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.36363636363636365}
{"q": "Connect fetal glucose exposure to fetal insulin secretion in GDM. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.5185185185185185}
{"q": "Why does fetal hyperglycemia trigger fetal hyperinsulinemia? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4090909090909091}
{"q": "Explain the fetal pancreatic insulin response to increased glucose exposure.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.36363636363636365}
{"q": "Connect fetal glucose exposure to fetal insulin secretion in GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4166666666666667}
{"q": "In mechanistic steps, why does fetal hyperglycemia trigger fetal hyperinsulinemia?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.5185185185185185}
{"q": "Explain the fetal pancreatic insulin response to increased glucose exposure. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.42857142857142855}
{"q": "Connect fetal glucose exposure to fetal insulin secretion in GDM. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4166666666666667}
{"q": "In mechanistic steps, connect fetal glucose exposure to fetal insulin secretion in GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.46153846153846156}
{"q": "Why does fetal hyperglycemia trigger fetal hyperinsulinemia? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.5185185185185185}
{"q": "Explain the fetal pancreatic insulin response to increased glucose exposure. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23076923076923078}
{"q": "Explain how inadequate beta-cell adaptation leads to GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.05555555555555555}
{"q": "In mechanistic steps, why does beta-cell compensation failure produce gestational diabetes?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23529411764705882}
{"q": "Explain how inadequate beta-cell adaptation leads to GDM. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3548387096774194}
{"q": "Why does beta-cell compensation failure produce gestational diabetes? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Why does beta-cell compensation failure produce gestational diabetes?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21212121212121213}
{"q": "In mechanistic steps, explain how inadequate beta-cell adaptation leads to GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.09090909090909091}
{"q": "Why does beta-cell compensation failure produce gestational diabetes? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.39473684210526316}
{"q": "Explain how inadequate beta-cell adaptation leads to GDM. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.05555555555555555}
{"q": "Explain how obesity increases GDM risk (mechanistic linkage).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4482758620689655}
{"q": "In mechanistic steps, why do age/BMI/family history increase the incidence of GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1111111111111111}
{"q": "Explain how obesity increases GDM risk (mechanistic linkage). Include key intermediates and directionality.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5}
{"q": "Why do age/BMI/family history increase the incidence of GDM? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.11538461538461539}
{"q": "Why do age/BMI/family history increase the incidence of GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1111111111111111}
{"q": "In mechanistic steps, explain how obesity increases GDM risk (mechanistic linkage).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5151515151515151}
{"q": "Why do age/BMI/family history increase the incidence of GDM? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23333333333333334}
{"q": "Explain how obesity increases GDM risk (mechanistic linkage). Use a concise 4\u20136 step causal chain.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4375}
{"q": "Why does GDM prevalence vary across populations (background T2DM linkage)?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.34210526315789475}
{"q": "In mechanistic steps, explain the relationship between background T2DM rates and GDM prevalence.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.32142857142857145}
{"q": "Why does GDM prevalence vary across populations (background T2DM linkage)? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3684210526315789}
{"q": "Explain the relationship between background T2DM rates and GDM prevalence. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21739130434782608}
{"q": "Explain the relationship between background T2DM rates and GDM prevalence.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.32142857142857145}
{"q": "In mechanistic steps, why does GDM prevalence vary across populations (background T2DM linkage)?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.34210526315789475}
{"q": "Explain the relationship between background T2DM rates and GDM prevalence. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.38235294117647056}
{"q": "Why does GDM prevalence vary across populations (background T2DM linkage)? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20689655172413793}
{"q": "Why is routine GDM screening commonly performed at 24\u201328 weeks?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "In mechanistic steps, explain the rationale for the 24\u201328 week screening window.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2777777777777778}
{"q": "Why is routine GDM screening commonly performed at 24\u201328 weeks? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.36363636363636365}
{"q": "Explain the rationale for the 24\u201328 week screening window. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Explain the rationale for the 24\u201328 week screening window.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2777777777777778}
{"q": "In mechanistic steps, why is routine GDM screening commonly performed at 24\u201328 weeks?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Explain the rationale for the 24\u201328 week screening window. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4827586206896552}
{"q": "Why is routine GDM screening commonly performed at 24\u201328 weeks? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Why is postpartum OGTT recommended after GDM, and when should it be done?", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.15625}
{"q": "In mechanistic steps, explain how postpartum OGTT detects persistent dysglycemia after GDM.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.13157894736842105}
{"q": "Why is postpartum OGTT recommended after GDM, and when should it be done? Include key intermediates and directionality.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.23529411764705882}
{"q": "Explain how postpartum OGTT detects persistent dysglycemia after GDM. Use a concise 4\u20136 step causal chain.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.08571428571428572}
{"q": "Explain how postpartum OGTT detects persistent dysglycemia after GDM.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.13157894736842105}
{"q": "In mechanistic steps, why is postpartum OGTT recommended after GDM, and when should it be done?", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.12903225806451613}
{"q": "Explain how postpartum OGTT detects persistent dysglycemia after GDM. Include key intermediates and directionality.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.28125}
{"q": "Why is postpartum OGTT recommended after GDM, and when should it be done? Use a concise 4\u20136 step causal chain.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.08823529411764706}
{"q": "How do diagnostic thresholds influence GDM prevalence and management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "In mechanistic steps, explain why different criteria/thresholds produce different GDM rates.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "How do diagnostic thresholds influence GDM prevalence and management? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4117647058823529}
{"q": "Explain why different criteria/thresholds produce different GDM rates. Use a concise 4\u20136 step causal chain.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain why different criteria/thresholds produce different GDM rates.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "In mechanistic steps, how do diagnostic thresholds influence GDM prevalence and management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.17391304347826086}
{"q": "Explain why different criteria/thresholds produce different GDM rates. Include key intermediates and directionality.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "How do diagnostic thresholds influence GDM prevalence and management? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "What glucose targets are used in GDM monitoring and why do they matter?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "In mechanistic steps, explain how fasting and postprandial targets guide therapy in GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "What glucose targets are used in GDM monitoring and why do they matter? Include key intermediates and directionality.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain how fasting and postprandial targets guide therapy in GDM. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how fasting and postprandial targets guide therapy in GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "In mechanistic steps, what glucose targets are used in GDM monitoring and why do they matter?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain how fasting and postprandial targets guide therapy in GDM. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4482758620689655}
{"q": "What glucose targets are used in GDM monitoring and why do they matter? Use a concise 4\u20136 step causal chain.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Describe the stepwise management of GDM (diet/exercise \u2192 medication).", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1}
{"q": "In mechanistic steps, when is pharmacotherapy indicated in GDM and what options are used?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2631578947368421}
{"q": "Describe the stepwise management of GDM (diet/exercise \u2192 medication). Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.28}
{"q": "When is pharmacotherapy indicated in GDM and what options are used? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "When is pharmacotherapy indicated in GDM and what options are used?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.29411764705882354}
{"q": "In mechanistic steps, describe the stepwise management of GDM (diet/exercise \u2192 medication).", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1}
{"q": "When is pharmacotherapy indicated in GDM and what options are used? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4827586206896552}
{"q": "Describe the stepwise management of GDM (diet/exercise \u2192 medication). Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.05555555555555555}
{"q": "How does treating hyperglycemia reduce adverse maternal/fetal outcomes?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "In mechanistic steps, explain how glycemic control improves pregnancy outcomes in GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3125}
{"q": "How does treating hyperglycemia reduce adverse maternal/fetal outcomes? Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.52}
{"q": "Explain how glycemic control improves pregnancy outcomes in GDM. Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Explain how glycemic control improves pregnancy outcomes in GDM.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.26666666666666666}
{"q": "In mechanistic steps, how does treating hyperglycemia reduce adverse maternal/fetal outcomes?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23529411764705882}
{"q": "Explain how glycemic control improves pregnancy outcomes in GDM. Include key intermediates and directionality.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4642857142857143}
{"q": "How does treating hyperglycemia reduce adverse maternal/fetal outcomes? Use a concise 4\u20136 step causal chain.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.29411764705882354}
{"q": "Explain how age increases the risk of gestational diabetes mellitus (GDM).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.48717948717948717}
{"q": "Why is age considered a risk factor for GDM?", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4166666666666667}
{"q": "Explain how bmi increases the risk of gestational diabetes mellitus (GDM).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5714285714285714}
{"q": "Why is bmi considered a risk factor for GDM?", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.39285714285714285}
{"q": "Explain how family history increases the risk of gestational diabetes mellitus (GDM).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.48717948717948717}
{"q": "Why is family history considered a risk factor for GDM?", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.3333333333333333}
{"q": "Explain how maternal age increases the risk of gestational diabetes mellitus (GDM).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4878048780487805}
{"q": "Why is maternal age considered a risk factor for GDM?", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.38461538461538464}
{"q": "Explain how ethnicity increases the risk of gestational diabetes mellitus (GDM).", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5151515151515151}
{"q": "Why is ethnicity considered a risk factor for GDM?", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.39285714285714285}
{"q": "Explain how previous infant with macrosomia increases the risk of gestational diabetes mellitus (GDM).", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.3157894736842105}
{"q": "Why is previous infant with macrosomia considered a risk factor for GDM?", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.41935483870967744}
{"q": "Explain how GDM contributes to macrosomia and the causal steps involved.", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.2571428571428571}
{"q": "What mechanisms link maternal dysglycemia to macrosomia?", "frame": "B", "soft": true, "covered_edges": ["CROSSES_PLACENTA"], "drift_ratio": 0.23333333333333334}
{"q": "Explain how GDM contributes to shoulder dystocia and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "What mechanisms link maternal dysglycemia to shoulder dystocia?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.45454545454545453}
{"q": "Explain how GDM contributes to neonatal hypoglycemia and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.45454545454545453}
{"q": "What mechanisms link maternal dysglycemia to neonatal hypoglycemia?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.5161290322580645}
{"q": "Explain how GDM contributes to stillbirth and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13043478260869565}
{"q": "What mechanisms link maternal dysglycemia to stillbirth?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4090909090909091}
{"q": "Explain how GDM contributes to preterm birth and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4838709677419355}
{"q": "What mechanisms link maternal dysglycemia to preterm birth?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4838709677419355}
{"q": "Explain how GDM contributes to lga and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "What mechanisms link maternal dysglycemia to lga?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.48}
{"q": "Explain how GDM contributes to large for gestational age and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "What mechanisms link maternal dysglycemia to large for gestational age?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how GDM contributes to nicu and the causal steps involved.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.09090909090909091}
{"q": "What mechanisms link maternal dysglycemia to nicu?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.48}
{"q": "How is GDM associated with maternal outcome: type 2 diabetes?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4358974358974359}
{"q": "Explain mechanistic or clinical links between GDM and type 2 diabetes.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.40540540540540543}
{"q": "How is GDM associated with maternal outcome: hypertension?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain mechanistic or clinical links between GDM and hypertension.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30434782608695654}
{"q": "How is GDM associated with maternal outcome: cesarean?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "Explain mechanistic or clinical links between GDM and cesarean.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2916666666666667}
{"q": "How is GDM associated with maternal outcome: preeclampsia?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "Explain mechanistic or clinical links between GDM and preeclampsia.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.34615384615384615}
{"q": "How is GDM associated with maternal outcome: caesarean?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25925925925925924}
{"q": "Explain mechanistic or clinical links between GDM and caesarean.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "How is GDM associated with maternal outcome: c-section?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20833333333333334}
{"q": "Explain mechanistic or clinical links between GDM and c-section.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "How is GDM associated with maternal outcome: postpartum diabetes?", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.37037037037037035}
{"q": "Explain mechanistic or clinical links between GDM and postpartum diabetes.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.07142857142857142}
{"q": "What is the role of hba1c in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why hba1c is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.125}
{"q": "What is the role of ogtt in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why ogtt is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.11764705882352941}
{"q": "What is the role of oral glucose tolerance test in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why oral glucose tolerance test is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2777777777777778}
{"q": "What is the role of cgm in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why cgm is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.11764705882352941}
{"q": "What is the role of gct in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why gct is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.11764705882352941}
{"q": "What is the role of continuous glucose monitoring in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why continuous glucose monitoring is used in GDM care.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "What is the role of smbg in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why smbg is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.11764705882352941}
{"q": "What is the role of fpg in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why fpg is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.11764705882352941}
{"q": "What is the role of glucose challenge test in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why glucose challenge test is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "What is the role of fasting plasma glucose in screening/diagnosing/monitoring GDM?", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain when and why fasting plasma glucose is used in GDM care.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Explain how placental lactogen contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.07142857142857142}
{"q": "What role does placental lactogen play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.08333333333333333}
{"q": "Explain how placental hormones contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.07142857142857142}
{"q": "What role does placental hormones play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.08333333333333333}
{"q": "Explain how progesterone contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "What role does progesterone play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how estrogen contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "What role does estrogen play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how adiponectin contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "What role does adiponectin play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how human placental lactogen contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.07142857142857142}
{"q": "What role does human placental lactogen play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.08333333333333333}
{"q": "Explain how leptin contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "What role does leptin play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how cortisol contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "What role does cortisol play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how growth hormone contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.35294117647058826}
{"q": "What role does growth hormone play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Explain how prolactin contributes to insulin resistance in pregnancy.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "What role does prolactin play in pregnancy metabolism relevant to GDM?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Explain how insulin is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is insulin recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1}
{"q": "Explain how diet is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is diet recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Explain how lifestyle is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is lifestyle recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Explain how metformin is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is metformin recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Explain how exercise is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is exercise recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Explain how glyburide is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is glyburide recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Explain how glibenclamide is used to manage GDM and what outcomes it targets.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1875}
{"q": "When is glibenclamide recommended in GDM management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "What is the significance of the threshold/timing '5.5 mmol/l' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '5.5 mmol/l' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '95 mg/dL' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '95 mg/dL' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '140 mg/dL' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '140 mg/dL' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '95mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '95mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '7.8 mmol/l' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.19047619047619047}
{"q": "Explain how '7.8 mmol/l' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '140mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '140mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '4-12 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain how '4-12 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '92 mg/dL' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '92 mg/dL' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '153 mg/dL' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '153 mg/dL' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '5.3 mmol/L' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '5.3 mmol/L' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '39 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21739130434782608}
{"q": "Explain how '39 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '120 mg/dL' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '120 mg/dL' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '30 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain how '30 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '19 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Explain how '19 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '22 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Explain how '22 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '26 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Explain how '26 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '36 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21739130434782608}
{"q": "Explain how '36 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '5.5mmol/l' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.17391304347826086}
{"q": "Explain how '5.5mmol/l' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '6 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21739130434782608}
{"q": "Explain how '6 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '110mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '110mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '7.8mmol/l' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20833333333333334}
{"q": "Explain how '7.8mmol/l' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '125mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '125mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '199mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '199mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '126mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '126mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '11.1mmol/l' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25925925925925924}
{"q": "Explain how '11.1mmol/l' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '200mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24}
{"q": "Explain how '200mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '18 mg/dl' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2727272727272727}
{"q": "Explain how '18 mg/dl' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '24-28 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain how '24-28 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '15 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Explain how '15 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '5.1 mmol/L' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '5.1 mmol/L' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '180 mg/dL' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain how '180 mg/dL' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '8.5 mmol/L' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.19047619047619047}
{"q": "Explain how '8.5 mmol/L' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '39-40 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain how '39-40 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "What is the significance of the threshold/timing '37-38 weeks' in GDM diagnosis or management?", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain how '37-38 weeks' is used in guideline timing/targets for GDM.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 THRESHOLD_CRITERIA, and why this progression matters clinically.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to THRESHOLD_CRITERIA in GDM physiology/pathophysiology.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and THRESHOLD_CRITERIA with intermediate steps.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: THRESHOLD_CRITERIA \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Build a stepwise explanation connecting THRESHOLD_CRITERIA to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect THRESHOLD_CRITERIA and MONITORING_TARGETS with intermediate steps.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: TREATED_BY \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Build a stepwise explanation connecting TREATED_BY to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect TREATED_BY and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21739130434782608}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21739130434782608}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4827586206896552}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5161290322580645}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4827586206896552}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3125}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and STIMULATES_INSULIN with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.375}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4827586206896552}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5161290322580645}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and INCREASES_RISK with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4827586206896552}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3125}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and CROSSES_PLACENTA with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.375}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.07692307692307693}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.0625}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23809523809523808}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.07692307692307693}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.0625}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23809523809523808}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3225806451612903}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3076923076923077}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2962962962962963}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5862068965517241}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5714285714285714}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and BETA_CELL_LIMITATION with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.65625}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3225806451612903}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3076923076923077}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and INCREASES_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2962962962962963}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3333333333333333}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.375}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.375}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.43333333333333335}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.46875}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and BETA_CELL_LIMITATION with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5}
{"q": "Explain the causal chain: TREATED_BY \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3125}
{"q": "Build a stepwise explanation connecting TREATED_BY to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.36363636363636365}
{"q": "Using a mechanistic chain, connect TREATED_BY and CROSSES_PLACENTA with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.38461538461538464}
{"q": "Explain the causal chain: TREATED_BY \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.18181818181818182}
{"q": "Build a stepwise explanation connecting TREATED_BY to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Using a mechanistic chain, connect TREATED_BY and STIMULATES_INSULIN with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "Explain the causal chain: TREATED_BY \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.375}
{"q": "Build a stepwise explanation connecting TREATED_BY to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Using a mechanistic chain, connect TREATED_BY and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4090909090909091}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23529411764705882}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and CROSSES_PLACENTA with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3448275862068966}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and STIMULATES_INSULIN with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23809523809523808}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5862068965517241}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5714285714285714}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and INCREASES_RISK with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.65625}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30303030303030304}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.43333333333333335}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.46875}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.375}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.4090909090909091}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3125}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.36363636363636365}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.38461538461538464}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23529411764705882}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3448275862068966}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3333333333333333}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.375}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.375}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30303030303030304}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.18181818181818182}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23809523809523808}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6428571428571429}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to TREATED_BY in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5161290322580645}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and TREATED_BY with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.65625}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5714285714285714}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and IMPROVES_OUTCOMES with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4166666666666667}
{"q": "Explain the causal chain: TREATED_BY \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting TREATED_BY to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect TREATED_BY and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: TREATED_BY \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6428571428571429}
{"q": "Build a stepwise explanation connecting TREATED_BY to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5161290322580645}
{"q": "Using a mechanistic chain, connect TREATED_BY and INCREASES_RISK with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.65625}
{"q": "Explain the causal chain: TREATED_BY \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Build a stepwise explanation connecting TREATED_BY to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2631578947368421}
{"q": "Using a mechanistic chain, connect TREATED_BY and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.391304347826087}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to TREATED_BY in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and TREATED_BY with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2631578947368421}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.391304347826087}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5714285714285714}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and INCREASES_RISK with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.4166666666666667}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.375}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.375}
{"q": "Explain the causal chain: SCREEN_24_28_WEEKS \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting SCREEN_24_28_WEEKS to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect SCREEN_24_28_WEEKS and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.4}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and STIMULATES_INSULIN with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2962962962962963}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2608695652173913}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.34782608695652173}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and IMPROVES_OUTCOMES with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.23809523809523808}
{"q": "Explain the causal chain: TREATED_BY \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20833333333333334}
{"q": "Build a stepwise explanation connecting TREATED_BY to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.18518518518518517}
{"q": "Using a mechanistic chain, connect TREATED_BY and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30303030303030304}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.09523809523809523}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20833333333333334}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.125}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.26666666666666666}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23076923076923078}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30434782608695654}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24242424242424243}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.09090909090909091}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.09523809523809523}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20833333333333334}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.125}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.26666666666666666}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2777777777777778}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and CROSSES_PLACENTA with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3548387096774194}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.32142857142857145}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and STIMULATES_INSULIN with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.45714285714285713}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2777777777777778}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3548387096774194}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 POSTPARTUM_OGTT, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.23333333333333334}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to POSTPARTUM_OGTT in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.06451612903225806}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and POSTPARTUM_OGTT with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.10344827586206896}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and BETA_CELL_LIMITATION with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and CROSSES_PLACENTA with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and STIMULATES_INSULIN with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2608695652173913}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.34782608695652173}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.23809523809523808}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23076923076923078}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30434782608695654}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2631578947368421}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and STIMULATES_INSULIN with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.20833333333333334}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.18518518518518517}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30303030303030304}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.16666666666666666}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.24242424242424243}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.32142857142857145}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.45714285714285713}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.4}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2962962962962963}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2631578947368421}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3333333333333333}
{"q": "Explain the causal chain: POSTPARTUM_OGTT \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.23333333333333334}
{"q": "Build a stepwise explanation connecting POSTPARTUM_OGTT to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.06451612903225806}
{"q": "Using a mechanistic chain, connect POSTPARTUM_OGTT and MONITORING_TARGETS with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.10344827586206896}
{"q": "Explain the causal chain: SCREEN_24_28_WEEKS \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.09090909090909091}
{"q": "Build a stepwise explanation connecting SCREEN_24_28_WEEKS to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.13636363636363635}
{"q": "Using a mechanistic chain, connect SCREEN_24_28_WEEKS and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Explain the causal chain: SCREEN_24_28_WEEKS \u2192 THRESHOLD_CRITERIA, and why this progression matters clinically.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Build a stepwise explanation connecting SCREEN_24_28_WEEKS to THRESHOLD_CRITERIA in GDM physiology/pathophysiology.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect SCREEN_24_28_WEEKS and THRESHOLD_CRITERIA with intermediate steps.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: THRESHOLD_CRITERIA \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Build a stepwise explanation connecting THRESHOLD_CRITERIA to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect THRESHOLD_CRITERIA and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.625}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6451612903225806}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5862068965517241}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6896551724137931}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6470588235294118}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6896551724137931}
{"q": "Explain the causal chain: INCREASES_RISK \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.46153846153846156}
{"q": "Build a stepwise explanation connecting INCREASES_RISK to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5862068965517241}
{"q": "Using a mechanistic chain, connect INCREASES_RISK and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5185185185185185}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.43333333333333335}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to TREATED_BY in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3793103448275862}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and TREATED_BY with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2962962962962963}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.48484848484848486}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5333333333333333}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.44}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5806451612903226}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.4838709677419355}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5862068965517241}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.1935483870967742}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3103448275862069}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2222222222222222}
{"q": "Explain the causal chain: POSTPARTUM_T2DM_RISK \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5161290322580645}
{"q": "Build a stepwise explanation connecting POSTPARTUM_T2DM_RISK to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5357142857142857}
{"q": "Using a mechanistic chain, connect POSTPARTUM_T2DM_RISK and CROSSES_PLACENTA with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2692307692307692}
{"q": "Explain the causal chain: TREATED_BY \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.43333333333333335}
{"q": "Build a stepwise explanation connecting TREATED_BY to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.3793103448275862}
{"q": "Using a mechanistic chain, connect TREATED_BY and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2962962962962963}
{"q": "Explain the causal chain: TREATED_BY \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15384615384615385}
{"q": "Build a stepwise explanation connecting TREATED_BY to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Using a mechanistic chain, connect TREATED_BY and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain the causal chain: TREATED_BY \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1111111111111111}
{"q": "Build a stepwise explanation connecting TREATED_BY to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.23529411764705882}
{"q": "Using a mechanistic chain, connect TREATED_BY and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Explain the causal chain: TREATED_BY \u2192 THRESHOLD_CRITERIA, and why this progression matters clinically.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Build a stepwise explanation connecting TREATED_BY to THRESHOLD_CRITERIA in GDM physiology/pathophysiology.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect TREATED_BY and THRESHOLD_CRITERIA with intermediate steps.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 STIMULATES_INSULIN, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1111111111111111}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to STIMULATES_INSULIN in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and STIMULATES_INSULIN with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 TREATED_BY, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15384615384615385}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to TREATED_BY in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15789473684210525}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and TREATED_BY with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.22727272727272727}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.625}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6451612903225806}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and INCREASES_RISK with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.5862068965517241}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.48484848484848486}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5333333333333333}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.44}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 MONITORING_TARGETS, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to MONITORING_TARGETS in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and MONITORING_TARGETS with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: FAILURE_LEADS_TO_GDM \u2192 THRESHOLD_CRITERIA, and why this progression matters clinically.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Build a stepwise explanation connecting FAILURE_LEADS_TO_GDM to THRESHOLD_CRITERIA in GDM physiology/pathophysiology.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Using a mechanistic chain, connect FAILURE_LEADS_TO_GDM and THRESHOLD_CRITERIA with intermediate steps.", "frame": "E", "soft": false, "covered_edges": ["SCREEN_24_28_WEEKS", "THRESHOLD_CRITERIA", "POSTPARTUM_OGTT"], "drift_ratio": 0.0}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.26666666666666666}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain the causal chain: BETA_CELL_LIMITATION \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.08333333333333333}
{"q": "Build a stepwise explanation connecting BETA_CELL_LIMITATION to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect BETA_CELL_LIMITATION and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.14285714285714285}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 INCREASES_RISK, and why this progression matters clinically.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6896551724137931}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to INCREASES_RISK in GDM physiology/pathophysiology.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6470588235294118}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and INCREASES_RISK with intermediate steps.", "frame": "C", "soft": true, "covered_edges": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "drift_ratio": 0.6896551724137931}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2727272727272727}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15384615384615385}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.35}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 VARIES_WITH_BACKGROUND_T2DM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to VARIES_WITH_BACKGROUND_T2DM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15384615384615385}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and VARIES_WITH_BACKGROUND_T2DM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2857142857142857}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5806451612903226}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.4838709677419355}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5862068965517241}
{"q": "Explain the causal chain: PERSISTENT_INSULIN_RESISTANCE \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Build a stepwise explanation connecting PERSISTENT_INSULIN_RESISTANCE to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Using a mechanistic chain, connect PERSISTENT_INSULIN_RESISTANCE and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.21428571428571427}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 IMPROVES_OUTCOMES, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.35294117647058826}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to IMPROVES_OUTCOMES in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30434782608695654}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and IMPROVES_OUTCOMES with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.42857142857142855}
{"q": "Explain the causal chain: CROSSES_PLACENTA \u2192 POSTPARTUM_T2DM_RISK, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5161290322580645}
{"q": "Build a stepwise explanation connecting CROSSES_PLACENTA to POSTPARTUM_T2DM_RISK in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.5357142857142857}
{"q": "Using a mechanistic chain, connect CROSSES_PLACENTA and POSTPARTUM_T2DM_RISK with intermediate steps.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2692307692307692}
{"q": "Explain the causal chain: MONITORING_TARGETS \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Build a stepwise explanation connecting MONITORING_TARGETS to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect MONITORING_TARGETS and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "F", "soft": false, "covered_edges": ["TREATED_BY", "MONITORING_TARGETS", "IMPROVES_OUTCOMES"], "drift_ratio": 0.10526315789473684}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 BETA_CELL_LIMITATION, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.26666666666666666}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to BETA_CELL_LIMITATION in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and BETA_CELL_LIMITATION with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2608695652173913}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2727272727272727}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15384615384615385}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.35}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2727272727272727}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.3}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Explain the causal chain: IMPROVES_OUTCOMES \u2192 CROSSES_PLACENTA, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.35294117647058826}
{"q": "Build a stepwise explanation connecting IMPROVES_OUTCOMES to CROSSES_PLACENTA in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.30434782608695654}
{"q": "Using a mechanistic chain, connect IMPROVES_OUTCOMES and CROSSES_PLACENTA with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.42857142857142855}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 PERSISTENT_INSULIN_RESISTANCE, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to PERSISTENT_INSULIN_RESISTANCE in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.15384615384615385}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and PERSISTENT_INSULIN_RESISTANCE with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2857142857142857}
{"q": "Explain the causal chain: VARIES_WITH_BACKGROUND_T2DM \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Build a stepwise explanation connecting VARIES_WITH_BACKGROUND_T2DM to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.2222222222222222}
{"q": "Using a mechanistic chain, connect VARIES_WITH_BACKGROUND_T2DM and SCREEN_24_28_WEEKS with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.32}
{"q": "Explain the causal chain: STIMULATES_INSULIN \u2192 FAILURE_LEADS_TO_GDM, and why this progression matters clinically.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.1111111111111111}
{"q": "Build a stepwise explanation connecting STIMULATES_INSULIN to FAILURE_LEADS_TO_GDM in GDM physiology/pathophysiology.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.10526315789473684}
{"q": "Using a mechanistic chain, connect STIMULATES_INSULIN and FAILURE_LEADS_TO_GDM with intermediate steps.", "frame": "A", "soft": true, "covered_edges": [], "drift_ratio": 0.25}
{"q": "Explain the causal chain: POSTPARTUM_OGTT \u2192 SCREEN_24_28_WEEKS, and why this progression matters clinically.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.2857142857142857}
{"q": "Build a stepwise explanation connecting POSTPARTUM_OGTT to SCREEN_24_28_WEEKS in GDM physiology/pathophysiology.", "frame": "D", "soft": true, "covered_edges": ["POSTPARTUM_OGTT"], "drift_ratio": 0.1724137931034483}